Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies

Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies

US Patent 9238693 · Granted Jan 19, 2016

Estimated economic value: $69,176,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PHF-tau antibodies and uses thereof2025
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses2024
Anti-IL-23 antibodies, compositions, methods and uses2024
Anti-IL-23 antibodies, compositions, methods and uses2024
Anti-IL-23 antibodies, compositions, methods and uses2024
Medical device for administering anti-IL-23 antibodies2024
Medical device for administering anti-IL-23 antibodies2024
Medical device for administering anti-IL-23 antibodies2024
Proteins comprising CD3 antigen binding domains and uses thereof2024
Proteins comprising kallikrein related peptidase 2 antigen binding domains and t2024
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use2024
Anti-IL-6 antibody2024